144 related articles for article (PubMed ID: 38719508)
1. Early increase in HbA1c trajectory predicts development of severe microangiopathy in patients with type 1 diabetes: the VISS study.
Arnqvist HJ; Ludvigsson J; Nordwall M
BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38719508
[TBL] [Abstract][Full Text] [Related]
2. Impact of HbA1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study.
Arnqvist HJ; Westerlund MC; Fredrikson M; Ludvigsson J; Nordwall M
Diabetes Care; 2022 Nov; 45(11):2675-2682. PubMed ID: 36094113
[TBL] [Abstract][Full Text] [Related]
3. Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden).
Nordwall M; Abrahamsson M; Dhir M; Fredrikson M; Ludvigsson J; Arnqvist HJ
Diabetes Care; 2015 Feb; 38(2):308-15. PubMed ID: 25510400
[TBL] [Abstract][Full Text] [Related]
4. Impact of Age of Onset, Puberty, and Glycemic Control Followed From Diagnosis on Incidence of Retinopathy in Type 1 Diabetes: The VISS Study.
Nordwall M; Fredriksson M; Ludvigsson J; Arnqvist HJ
Diabetes Care; 2019 Apr; 42(4):609-616. PubMed ID: 30705061
[TBL] [Abstract][Full Text] [Related]
5. HbA
Lind M; Pivodic A; Svensson AM; Ólafsdóttir AF; Wedel H; Ludvigsson J
BMJ; 2019 Aug; 366():l4894. PubMed ID: 31462492
[TBL] [Abstract][Full Text] [Related]
6. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
[TBL] [Abstract][Full Text] [Related]
7. A high mean-HbA1c value 3-15 months after diagnosis of type 1 diabetes in childhood is related to metabolic control, macroalbuminuria, and retinopathy in early adulthood--a pilot study using two nation-wide population based quality registries.
Samuelsson U; Steineck I; Gubbjornsdottir S
Pediatr Diabetes; 2014 May; 15(3):229-35. PubMed ID: 24119008
[TBL] [Abstract][Full Text] [Related]
8. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
9. HbA
Baldimtsi E; Amezcua S; Ulander M; Hyllienmark L; Olausson H; Ludvigsson J; Wahlberg J
Diabetes Metab Res Rev; 2024 Jul; 40(5):e3825. PubMed ID: 38878301
[TBL] [Abstract][Full Text] [Related]
10. Early risk stratification in pediatric type 1 diabetes.
Broe R
Acta Ophthalmol; 2015 Mar; 93 Thesis 1():1-19. PubMed ID: 25703648
[TBL] [Abstract][Full Text] [Related]
11. Long term risk of severe retinopathy in childhood-onset type 1 diabetes: a data linkage study.
White M; Sabin MA; Magnussen CG; O'Connell MA; Colman PG; Cameron F
Med J Aust; 2017 May; 206(9):398-401. PubMed ID: 28490305
[TBL] [Abstract][Full Text] [Related]
12. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.
Svensson MK; Tyrberg M; Nyström L; Arnqvist HJ; Bolinder J; Östman J; Gudbjörnsdottir S; Landin-Olsson M; Eriksson JW
Diabetes Metab Res Rev; 2015 Feb; 31(2):138-46. PubMed ID: 25044633
[TBL] [Abstract][Full Text] [Related]
13. Comment on Nordwall et al. Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308-315.
Takahara M
Diabetes Care; 2015 Aug; 38(8):e123. PubMed ID: 26207064
[No Abstract] [Full Text] [Related]
14. Response to Comment on Nordwall et al. Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308-315.
Nordwall M; Abrahamsson M; Dhir M; Fredrikson M; Ludvigsson J; Arnqvist HJ
Diabetes Care; 2015 Aug; 38(8):e124. PubMed ID: 26207065
[No Abstract] [Full Text] [Related]
15. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.
Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME
J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858
[TBL] [Abstract][Full Text] [Related]
16. Predictors of microvascular complications in type 1 diabetic patients at onset: the role of metabolic memory.
Giordano C; Amato MC; Ciresi A; Citarrella R; Mantione L; Accidenti M; Pantò F; Guarnotta V; Allotta ML; Criscimanna A; Galluzzo A
Eur J Intern Med; 2011 Jun; 22(3):266-74. PubMed ID: 21570646
[TBL] [Abstract][Full Text] [Related]
17. Ketoacidosis at diagnosis in childhood-onset diabetes and the risk of retinopathy 20years later.
Salardi S; Porta M; Maltoni G; Cerutti F; Rovere S; Iafusco D; Tumini S; Cauvin V; Zucchini S; Cadario F; dʾAnnunzio G; Toni S; Salvatoni A; Zedda MA; Schiaffini R;
J Diabetes Complications; 2016; 30(1):55-60. PubMed ID: 26598223
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
[TBL] [Abstract][Full Text] [Related]
19. ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.
Bjornstad P; Maahs DM; Rewers M; Johnson RJ; Snell-Bergeon JK
J Diabetes Complications; 2014; 28(6):762-6. PubMed ID: 25270733
[TBL] [Abstract][Full Text] [Related]
20. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
